Not a Lexis Advance subscriber? Try it out for free.


Mealey's PI/Product Liability - Bankruptcy Trustee, SEC Object To Shareholder Treatment In Insys Liquidation Plan

WILMINGTON, Del. - A federal bankruptcy trustee and the U.S. Securities and Exchange Commission on Jan. 6 objected to how a proposed liquidation plan for opioid maker Insys Therapeutics Inc. treats stockholders who will be left with worthless shares of the company (In Re: Insys Therapeutics, Inc., et al., No. 19-11292, D. Del. Bkcy.).
Find full version on lexis Advance®